Yasuyuki Mitani

Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice

Yasuyuki Mitani, Junko Yarimizu, Kyoko Saita et al. · Journal of Neuroscience · 2012 · 194 citations · Full text

Structure–function analysis of myomaker domains required for myoblast fusion

Douglas P. Millay, Dilani G. Gamage, Malgorzata E. Quinn et al. · Proceedings of the National Academy of Sciences · 2016 · 83 citations · Full text

Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition

Takuma Mihara, Kayoko Mihara, Junko Yarimizu et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 75 citations

Amelioration of cognitive deficits in plaque‐bearing <scp>A</scp>lzheimer's disease model mice through selective reduction of nascent soluble A42 without affecting other A pools

Yasuyuki Mitani, Junko Yarimizu, Hiroki Akashiba et al. · Journal of Neurochemistry · 2012 · 18 citations

Second-generation Gsms, Neurochemical Biomarkers, Amyloid Precursor Protein +19

Stereoselective Metabolism of Cibenzoline, an Antiarrhythmic Drug, by Human and Rat Liver Microsomes: Possible Involvement of CYP2D and CYP3A

Toshiro Niwa, Toshifumi Shiraga, Yasuyuki Mitani et al. · Drug Metabolism and Disposition · 2000 · 18 citations